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of the methodology and the indications of the test and types 
of response that are expected5. In this paper, we discuss the 
current indications, protocols, limitations and perspectives 
of this test.
Indications of the tilt test
The 2006 American Heart Association Scientific Statement 
on The Evaluation of Syncope does not recommend HUTT 
for evaluation of syncope, but such document has attracted 
widespread criticism, which will be commented on below6,7. 
In clinical practice, the indications described by the European 
Guidelines of Syncope are used5. These guidelines state 
that the HUTT shall be used for diagnostic purposes in the 
situations below.
Class I recommendation
In young patients, without obvious or suspected heart 
disease, with recurrent syncope of unexplained origin, in 
which the history is not typical enough for the diagnosis of 
neurally mediated syncope.
In cases of a single episode of unexplained syncope, which 
occurred in situation where there is high risk of physical 
injury or with occupational implications; or in cases of 
recurrent syncope in the absence of heart disease, or yet, if 
in patients with heart disease, the cardiac causes of syncope 
are ruled out.
In cases where the demonstration of susceptibility to 
neurally mediated syncope is clinically relevant.
Class II recommendation
When understanding the pattern of hemodynamic response 
during syncope may alter the treatment planning.
In the differentiation between convulsive syncope and 
epilepsy.
In diagnosis to differentiate between reflex syncope and 
orthostatic hypotension.
For the evaluation of patients that have had unexplained 
recurrent falls.
When dealing with patients with presyncope or 
recurrent dizziness.
In the evaluation of patients with recurrent syncope and 
psychiatric illnesses.
The European guidelines state that, in cases in which the 
test is recommended and in the absence of an associated 
heart disease, the positive result with reproduction of the 
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The head-up tilt test (HUTT) is widely used for investigation 
of syncope and presyncope, since it allows diagnosing different 
types of dysautonomia. The main cause of syncope is the 
vasovagal syndrome, the most common diagnosis among 
patients with HUTT indication. The test has been used 
for nearly 20 years, but many doctors are unaware of the 
methodology. After the cardiac causes of syncope are ruled 
out, the appropriate indication of the test and instructions to 
patients are important to ensure that the test will be carried out 
in a safe and relaxed manner. There are controversies in the 
literature over the diagnostic capacity and reliability of results. 
Studies with various protocols may explain the variability of 
results. This review describes the guidelines-recommended 
methodology and indications, complications, limitations and 
perspectives of this test.
Introduction
The head-up tilt test (HUTT) is a widely used method for 
investigation of syncope, presyncope, dizziness, palpitations 
related to orthostatism and dysautonomia symptoms1. 
However, the main indication has been to investigate the 
vasovagal syndrome (VVS). 
In 1986, Kenny et al2 reported, for the first time, the 
usefulness of HUTT in the investigation of patients with 
syncope of probable vasovagal origin. They noted that the 
exposure to a 60° tilt for 60 minutes triggered the vasovagal 
reflex in 66% of patients with syncope of unexplained origin. 
Since then, protocols of shorter duration or drug-potenciated 
protocols have been used, so as to increase sensitivity and 
shorten the execution time of the test. 
Lately, the test has been criticized due to a great variation 
in sensitivity and specificity rates in different studies. 
Furthermore, the result of the HUTT has well-defined 
therapeutic implications and the reproducibility is limited3,4.
The European Guidelines on Diagnosis and Management 
of Syncope, updated in 2009, describe the recommendations 
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spontaneous syncope is sufficient for defining the diagnosis 
of neurally mediated syncope.
The use of HUTT for controlling treatments or for monitoring 
the VVS in the long term has not been recommended. 
Even though the European guidelines on syncope do not 
recommend the HUTT for patients that have a typical clinical 
history of VVS, the tilt test is valuable in identifying the type of 
VVS (cardioinhibitory, vasodepressor or mixed). Some authors 
recommend different treatment options depending on the 
type of vasovagal syncope, so in this case, HUTT would serve 
as therapeutic guidance5,8. Pachon et al8 recently published a 
new therapeutic alternative for patients with neurocardiogenic 
syncope, which would be more suitable for patients with 
cardioinhibitory VVS.
Protocols
In the descriptions of previous protocols, the terms 
“sensitivity” and “positivity” get mixed up due to the absence 
of a gold standard test for diagnosing VVS. When the clinical 
diagnosis is considered to be the gold standard, the term 
“HUTT sensitivity” has been used, because the patient with 
the disease was selected according to the clinical history. 
When the test is carried out in patients with unexplained 
syncope, the term “positivity” is generally applied. However, 
in this review, the term “sensitivity” was standardized for both 
situations, in order to simplify the description of the studies, 
but it is understood that in many cases, the term represents 
only the positivity of the test. The use of clinical diagnosis as the 
gold standard has been criticized because of the subjectivity 
inherent in medical judgment. However, to date, no other 
method has proved to be more accurate.
Initially, the authors recommended only the orthostatic tilt 
for prolonged periods, without the use of drugs, which is called 
the extended passive protocol. In the analysis of five studies 
that evaluated the result of exposure to passive orthostasis, 
lasting at least 40 minutes, the sensitivity rates noted were 13%, 
25%, 31%, 35% and 75% (median of 31%)9-12. In contrast to 
the low sensitivity, the specificity was 100%, 100%, 95%, 92% 
and 89%, respectively (mean of 95%).
In an attempt to increase the diagnostic accuracy of HUTT, 
the administration of various sensitizing drugs was tested after 
a negative passive phase. 
Currently, isoproterenol and nitrate are the drugs most 
commonly used for this purpose. In the several studies 
conducted, the sensitivity of the test with nitrate ranged 
between 57.5% and 87%, and the specificity between 
70% and 100%, while the test with isoproterenol showed 
variations between 42% and 69% and between 70 and 90%, 
respectively9,11,13-15. Isoproterenol is being abandoned due 
to the lower sensitivity, inconvenience of intravenous access 
and side effects, especially in patients with ischemic heart 
disease16 (Table 1).
Initially, nitrate was used in the form of intravenous 
nitroglycerin, with sensitivity of 53% and specificity of 92%, 
considering only the sensitized phase17. In a subsequent 
study, the same researchers evaluated the effect of sublingual 
nitroglycerin10. Initially, patients lay on a table that was tilted up 
to an angle of 60° for 45 minutes (passive tilt), which resulted 
in low sensitivity (25%) and high specificity (100%). After 
administration of 300 mg of sublingual nitroglycerin, a positive 
response was observed in more than 26% of the patients and 
in 6% of the control group, resulting in a specificity of 94%. 
Similar data were presented by other authors in subsequent 
years9,15,18 (Table 1). 
The European guidelines on syncope, published in 2004, 
reported an analysis of studies that used 20 or 45 minutes 
of passive phase followed by sensitization with nitrate. The 
conclusion reached was that the sensitivity of tests of shorter 
or longer duration is similar (69% versus 62%), without any 
decrease in specificity (94% for the protocols with 20 minutes 
of passive phase)1. Since then, it is recommended that the 
HUTT should consist of 20 minutes of passive phase and 20 
Table 1 - Methodology and results of different studies with the sensitized tilt test







Raviele et al 199510 235 60º NTG 300 mg 45 20 51(65) 94 56(67)
Aerts et al 19979 32 70º DNIS 5 mg 45 15 87 70 81
Del Rosso et al 
199818 202 60º NTG 400 mg 20 25 70(74) 94(82) 81(83)
Ammirati et al 
199815 73 60º DNIS 1,25 mg 30 15 57(71) 100 62(75)
Bartoletti et al 
199938 84 60º NTG 400 mg 5 20 35 96 NA
Aerts et al 200528 38 70º NTG 400 mg - 30 82 84 83
































S - sample size; NTG - nitroglycerin; ISDN - isosorbide dinitrate; GTN - glyceryl trinitrate; ISOP - isoproterenol; NA - not available
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minutes of sensitized phase (nitroglycerin or isoproterenol). 
Thus, the classical protocol (without the use of sensitizing 
drugs) has been replaced by the protocol that combines the 
passive phase followed by the sensitized phase.
In Brazil, sublingual nitroglycerin has not been traded 
since 2002, so the vasodilator used is isosorbide dinitrate, at 
a dose of 1.25 mg (1/4 of the sublingual administration pill), 
as recommended by the Brazilian Guidelines for Evaluation 
and Treatment of Patients with Cardiac Arrhythmias, published 
in 200219. In three studies that evaluated the use of this drug 
during the HUTT, the sensitivity ranged from 57 to 87%, and 
specificity from 70 to 100%9,14,15. The dose of 1.25 mg was 
evaluated in only one of these studies and it was the one 
related to the highest specificity (100%)15.
The sensitization of the test with the use of nitrate 
reproduces the same types of vasovagal responses as the 
passive tilt: cardioinhibitory, vasodepressor and mixed20. 
However, the mechanism by which nitrate induces vasovagal 
syncope is still not understood, and the most studied 
hypotheses have been: 1. vasodilatation, 2. activation of the 
sympathetic nervous system, 3. direct action in the central 
nervous system (CNS), and 4. action in the central nervous 
system (CNS) via neurohormones20-22.
Recommended methodology
HUTT must be conducted in a quiet environment, with 
dimmed lighting and pleasant temperature. The monitoring is 
carried out by doctors and nursing technicians, trained for the 
test, and the presence of relatives is not recommended. The 
room must be equipped with cardiac resuscitation materials, 
although the use of such materials is rarely necessary19. Patients 
must fast for at least four hours for liquids and six hours for 
solids and they must lie down for at least ten minutes, before 
the tilting19. Venipuncture should be avoided in this phase, 
but if necessary, the resting time before the test should be 
increased to at least 20 minutes1. The test table has a footrest 
and safety straps and it can be tilted up to 60 or 70 degrees 
(Figure 1). Angles that are above and below the default 
configuration show lower specificity and lower sensitivity 
of HUTT, respectively1,23. Throughout the examination, 
electrocardiogram and blood pressure (BP) readings are used 
to monitor the patient. Ideally, BP should be monitored in a 
continuous and non-invasive way. If the BP is intermittently 
measured, the interval between measurements should be as 
small as possible, especially in the phase that is close to the 
positive result of the test. In patients aged over 40 and with 
a clinical history of syncope, the carotid sinus massage is also 
recommended, because during tilting, the sensitivity of this 
technique is higher, and it is also possible to evaluate the 
vasodepressor component24. The test can be carried out at any 
time of day, but when the goal is to study the reproducibility 
of results, it is important to repeat the test at the same time it 
is was previously carried out25.
Types of response to tilt testing
The Brazilian Guidelines for Evaluation and Treatment 
of Patients with Cardiac Arrhythmias considers the HUTT 
positivity criterion when there is reproduction of the 
Figure 1 - Table tilted at an angle of 70 degrees, with footrest and rest for the upper limb in which the BP will be measured. The Velcro straps allow securing the patient 
in case of loss of postural tone. The necessary equipment is (from the right to the left): device for noninvasive monitoring of BP, beat to beat, and BP curve and ECG 
monitoring devices.
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spontaneous symptoms associated with the hemodynamic 
collapse19. There is controversy surrounding the interruption 
of the test before the occurrence of syncope. Many authors 
consider that it is enough to stop the HUTT when the doctor 
believes that the loss of consciousness is imminent – phase 
called presyncope -, and there is no reason to subject the 
patient to the huge discomfort resulting from hypotension 
or bradycardia, which will allow defining the vasovagal 
response1,26,27. More recent studies have considered that the 
positivity criterion is the induction of syncope or presyncope, 
when associated with bradycardia or hypotension11,13,14,18,26,28.
A modified classification of VASIS (Vasovagal Syncope 
International Study) is the most accepted one to define 
the types of response to tilt testing: type 1 or mixed; 
type 2A or cardioinhibitory without asystole; type 2B or 
cardioinhibitory with asystole; and type 3 or vasodepressor 
(Table 2 and Figure 2)1.
However, the type of response to HUTT does not 
necessarily define the hemodynamic pattern of the patient’s 
clinical syncope. The ISSUE-2 study showed that 36% of 
patients with mixed or vasodepressor response to HUTT had 
asystole during a spontaneous episode recorded by the loop 
recorder29. Thus, more recently, it has been considered that 
the most important aspect of the response to tilt testing is the 
differentiation between reflex syncope and other forms of 
orthostatic intolerance5.
Other diagnoses obtained by means of the 
tilt test
Besides the vasovagal response, HUTT allows diagnosing 
other forms of dysautonomia and orthostatic intolerance. 
The carotid sinus hypersensitivity is confirmed if, during the 
massage, there is a ventricular pause that exceeds or is equal 
to three seconds or if there a drop in systolic blood pressure 
that is greater than or equal to 50 mmHg1. The massage during 
tilt allows diagnosing half of the patients with the disease that 
would not be diagnosed if the procedure was performed 
only in a supine position. In a retrospective study with 1,719 
patients, the diagnosis of carotid sinus hypersensitivity was 
made in 226 cases during the procedure in the supine position 
and in 217 cases only after repeating the procedure at a tilted 
position24. In addition, the continuous monitoring of BP during 
the HUTT makes it easier to evaluate the vasodepressor 
component, which is important for the diagnosis because, in 
most cases, syncope results both from the drop in HR and the 
decrease in BP - mixed response. 
Another frequent dysautonomia is the Postural Orthostatic 
Tachycardia Syndrome or Postural Tachycardia Syndrome, in 
which the patient complains mainly of palpitations, dizziness 
and presyncope related to orthostatism. HUTT is essential 
to confirm the diagnosis, which is considered positive when 
there is an increase in HR that is greater than or equal to 30 
bpm, after orthostatic exposure in relation to basal HR or 
maintenance of HR above 120 bpm during the tilt30. On the 
other hand, there is the chronotropic incompetence, which is 
characterized by the failure to increase the heart rate during 
the tilt, i.e., an increase of less than 10% of the baseline heart 
rate31. This diagnosis can only be made when there are no 
effects of negative chronotropic drugs.
HUTT also allows diagnosing other forms of orthostatic 
intolerance, such as the dysautonomic response, characterized 
by slow and progressive drop in BP to below 80 mmHg, 
without any drop in HR, associated with symptoms of 
hypotension such as sudoresis, dizziness and blurred vision31. 
The patient has these symptoms for at least five minutes 
without the occurrence of syncope, and at such moment, the 
examination shall be discontinued.
The primary diseases of the autonomic nervous system (Pure 
Autonomic Failure, Shy-Drager Syndrome and Multiple System 
Atrophy) or secondary autonomic failures to systemic diseases 
(Parkinson’s Syndrome, Diabetes mellitus and Amyloidosis) 
can also be evaluated by HUTT32. They are characterized by 
supine hypertension and orthostatic hypotension, which do 
not recover after the first few minutes of postural exposure. 
Depending on the intensity of the autonomic impairment, this 
postural hypotension may be of greater or lesser magnitude 
and it may be accompanied by insufficient increase in HR 
or not, thereby indicating more or less advanced degrees of 
autonomic failure. 
Complications
HUTT is a safe examination if it is carried out under the 
conditions recommended above and if the cardiac causes for 
syncope are ruled out. In this sense, before requesting this 
test, it is important to survey the clinical history of the syncope 
episode. If there is the suspicion of cardiac or neurological 
cause, the specific investigation must be conducted33. Leman 
et al16. reported the occurrence of ventricular fibrillation during 
a tilt test with the use of isoproterenol at a dose of 5 ug/kg/min, 
in an 80-year-old patient, with history of previous myocardial 
infarction and who was being tested for syncope, but who had 
not undergone an echocardiogram or had not been tested 
for myocardial ischemia prior to the HUTT. After successful 
defibrillation, the patient underwent coronary angiography, 
which revealed 99% obstruction of the circumflex artery.
Table 2 - Classification of positive responses to tilt testing
Type 1 or mixed
The heart rate (HR) drops at the time of 
the syncope, but not to less than 40 bpm. If 
there is a drop in HR to below 40 bpm, the 
drop lasts less than ten seconds. The blood 
pressure (BP) drops before the HR.
Type 2A or cardioinhibitory 
without asystole
The heart rate drops below 40 bpm for 
more than ten seconds. The BP drops 
before the HR.
Type 2B or cardioinhibitory 
with asystole
There is asystole that lasts more than three 
seconds. The decrease in BP precedes or 
coincides with the drop in HR.
Type 3 or vasodepressor HR does not drop more than 10% compared to the peak at the time of syncope.
Exception 1 - Chronotropic 
incompetence
There is no significant increase in HR 
during the tilt (i.e., less than 10% of the HR 
before the tilt).
Exception 2 - Postural 
Orthostatic Tachycardia 
Syndrome (POTS)
Excessive increase in HR (i.e., greater than 
130 bpm) both initially and throughout the tilt 
before the syncope.
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Figure 2 - Charts showing the behavior of BP and HR during different vasovagal responses and SPOT. A - mixed vasovagal response or type 1; B - cardioinhibitory 
vasovagal response with asystole or type 2B; C - vasodepressor vasovagal response or type 3; D - postural orthostatic tachycardia syndrome. Acronyms: DD - dorsal 
decubitus; TILT - orthostatic tilt; BP - blood pressure; HR - heart rate; N - nitrate.
In contrast, an English study attested to the safety of this 
test. The study included 1,969 elderly people aged over 60, 
44% of whom were over 75 years old. The tilt test consisted 
of a passive phase followed by a sensitized phase with using 
the passive protocol or the protocol sensitized by glyceryl 
trinitrate34. Only a 74-year-old patient had atrial fibrillation 
at the 26th minute of the passive tilt, which was the only 
cardiovascular event observed during the tests, and there 
was no neurological event. Another study conducted in Spain 
showed no complications during the examination of 1,219 
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individuals, including young and old people, in which the 
methodology with only the passive phase was used or the 
passive phase together with isoproterenol sensitization35.
The occurrence of prolonged asystole, as a result of 
vasovagal reflex induced by HUTT, is not rare, but in most 
cases, it is not necessary to initiate resuscitation, because the 
quick return to the supine position or Trendelenburg position 
is enough for regaining of consciousness. There have been 
reports of asystole of 73 seconds, which was reversed with 
resuscitation and atropine, without any sequelae after the 
examination36. The pauses usually last less than 30 seconds, 
but longer pauses are not considered major complications. 
Such pauses are considered exacerbated responses1.
Clinical use and limitations
Due to its capacity to reproduce the patient’s symptoms in 
a laboratory, together with the corroboration of hemodynamic 
changes, the tilt test has been used to confirm the diagnosis of 
VVS for over 20 years. Specific guidelines recommend the use 
for diagnosis of syncope of unexplained origin, presyncope, 
dizziness, falls and seizures.
In 2006, the American Heart Association Scientific 
Statement suggested that HUTT contributed little to the 
diagnostic investigation6. The criticism was about the 
sensitivity, specificity, accuracy and reproducibility, and only 
four references were provided to justify the disqualification of 
the test - while the European Guidelines on syncope were not 
cited. On the other hand, the Ad Hoc Syncope Consortium 
argued that such document was incomplete, showed only 
a partial view of the disease context and failed to mention 
current and important evidence, such as the European 
Guidelines on syncope7.
Other authors have also questioned the validity of HUTT3,4. 
With regard to sensitivity and specificity, some people consider 
that the results are very different, depending on the method 
used, specially the degree of tilt, duration of the passive 
phase, the use or non-use of sensitizing drugs and the type 
of population studied. The variation in results is justified 
exactly by the evaluation of studies that use very different 
methodologies, which is one of the reasons that led to the 
standardization of the test in the European Guidelines. Petkar e 
Fitzpatrick3 criticize the low sensitivity of the test with only the 
passive phase and the decrease in specificity when sensitizing 
drugs are used. The authors illustrate the low specificity by 
mentioning a study that found 55% false positives in a test 
sensitized with isoproterenol3,37. However, in this study, the tilt 
test was carried out with a tilt of 80 degrees, which is known 
to reduce the specificity and it is not recommended1. Likewise, 
when one analyzes more recent studies, it is possible to 
notice a significant decrease in specificity when, in sensitized 
protocols, the duration of the passive phase is equal to or more 
than 30 minutes. Protocols with shorter passive phases, or 
even without a passive phase, followed by sensitization with 
nitrate or isoproterenol, are linked with specificities that range 
from 84 to 97%18,28,38, whereas, in studies that used a more 
prolonged passive phase, there was a decrease in specificities 
(48 to 70%)9,11,15. Therefore, limiting the total duration of the 
examination seems to guarantee good specificity.
The sensitivity of the passive phase alone is highly variable, 
but most studies have found low rates of positivity. When this 
phase lasted between 40 and 45 minutes, the sensitivities 
found were 13%, 25%, 31% and 35%9-11,26. It was only when 
the duration was 60 minutes that the positivity increased to 
75% yet the specificity decreased to 89%12 . As for the tests 
sensitized with nitrate, for example, the sensitivity varies 
between 53 and 87%9,11,13-15,17,26.
Considering that the combination with drugs significantly 
increases the sensitivity of HUTT and that the decrease in 
specificity may be acceptable, the combined protocol is 
most suitable for clinical use in the diagnostic investigation 
of syncope.
Tilt test in the prognostic evaluation
Some studies have been conducted to evaluate the ability 
of the HUTT result to predict the clinical evolution4. Hachul 
et al39 reported that, after the institution of the treatment 
for Vasovagal Syndrome, the HUTT with negative result 
was associated with the lower recurrence of symptoms in 
relation to the positive result (4.9 versus 52.4%, in 12 months, 
p<0.0001). Bastos et al40 analyzed the capacity of the test to 
predict the recurrence of symptoms after discontinuation of 
medication and they found that 84% of patients with positive 
HUTT, under this condition, developed the symptoms again 
after being monitored for 12 months. Moreover, the average 
time for the first relapse was significantly shorter in patients 
with positive test compared to those with a negative test. 
However, some authors found different results. Grim et al41 
monitored 80 patients with whom the HUTT test had been 
carried out, with at least one prior episode of syncope. Only 14 
patients of such patients had a positive result. After monitoring 
the patients for 23 months, on average, the authors concluded 
that the result of the HUTT was not useful to predict the clinical 
course of patients, but the presence of two or more previous 
episodes of syncope was. Sheldon et al42 demonstrated that 
the risk of syncope in two years was similar among patients 
with positive and negative HUTT. The test method used was a 
single phase sensitized with isoproterenol, at a tilt of 80o and 
maximum duration of ten minutes, which is quite different 
from what is used today.
The ISSUE study is also used by some authors to justify the 
low prognostic value of HUTT3,4,43. One hundred and eleven 
patients were included, and only 29 of them (26%) had a 
positive HUTT. A device to monitor electrocardiographic 
events (loop recorder) was implanted in all patients, and it was 
possible to notice that there was a relationship between the 
HUTT positivity and the bradycardias recorded in the event 
monitoring device. However, the etiologic diagnosis of syncope 
was possible in only 20 (18%) patients (16 due to asystole lasting 
longer than three seconds, three due to severe bradycardia and 
one due to paroxysmal supraventricular tachycardia), despite 
the use of an implantable device that could monitor events for 
up to 15 months. The small number of patients with positive 
outcome in each one of the tests makes it difficult to reach a 
more reliable conclusion on the data. 
In a recent study, 276 patients diagnosed with VVS were 
monitored for two years. The HUTT, which was carried out 
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as recommended by European guidelines, was positive in 
37% of patients. The positive predictive factors for syncope 
recurrence were the number of prior syncope events, female 
gender and bronchial asthma, but not the HUTT44. Therefore, 
before the emergence of new studies, the result of HUTT does 
not seem to be useful in the prognostic evaluation of syncope.
Tilt test in evaluation of the therapeutic 
response
With respect to the repetition of HUTT to assess the 
therapeutic response, two variables should be discussed. A 
possible limitation of this analysis is the poor reproducibility 
of HUTT when the first result is positive, which ranges from 
31 to 92%1. On the other hand, the reproducibility of the 
negative test is better - 85 to 94%1 . Another variable is the 
very failure to define which medication is really effective in 
treating the disease. There have been attempts to explain the 
failure of the therapy with metoprolol, by attributing the cause 
of such failure to the selection of patients with positive result 
in the HUTT sensitized with isoproterenol4,45. However, a 
randomized and controlled study with atenolol also showed no 
reduction in symptoms, although the selection of patients was 
based on the clinical characterization of vasovagal syndrome, 
regardless of the outcome of HUTT46. The failure of the therapy 
with the use of a pacemaker has also been attributed to the 
selection of patients with bradycardia during the HUTT3,4. 
However, further studies are needed to define the efficacy of 
artificial cardiac stimulation and, this way, justify the negative 
results of previous studies by a selection bias.
When is the tilt test most important?
Even though the prognosis of patients with syncope and 
without heart disease is excellent, many of them are tormented 
by the absence of a definitive diagnosis, and the subsequent 
anxiety may result in more frequent episodes of vasovagal 
syncope. Another good example of the importance of the tilt 
test is the investigation of patients with a history of sudden 
syncope and with negative cardiac evaluation. The HUTT 
can reproduce the syncope without prodromes, which occur 
either because the patient does not notice the drop in blood 
pressure or heart rate, or because the hemodynamic collapse 
develops very quickly.
The VVS is responsible for 31 to 34% of the syncope 
cases in the elderly47,48 In this population, it is especially 
important to perform the HUTT after the cardiac causes are 
ruled out, because the correct diagnosis and appropriate 
treatment can prevent falls and complications resulting from 
the syncope, such as fractures and subdural hematoma. 
In addition, the HUTT increases the chance of identifying 
carotid sinus hypersensitivity, which is linked with up to 20% 
of syncopes in the elderly49. The test is also very useful in the 
differentiation with epileptic symptoms, and the identification 
of the dysautonomia syndrome in these patients avoids the 
social limitations imposed by the diagnosis of epilepsy and 
side-effects resulting from the anticonvulsant medication50.
In addition, it is possible to characterize the psychogenic 
syncope during the HUTT, when the patient simulates the 
syncope episode, without any sign of related hemodynamic 
change51. Other diagnoses associated with syncope, such as 
orthostatic intolerance and Postural Orthostatic Tachycardia 
Syndrome, also may be revealed or confirmed by HUTT.
Perspectives
In an attempt to improve the specificity of the test and 
patients, shorter HUTT protocols have been tested. In this 
sense, the methods under study have evaluated the reduction 
in time or the exclusion of the passive phase, and the results 
so far are conflicting. 
In patients with unexplained syncope, Bartoletti et al38 
compared the results of passive tilt for 45 minutes versus tilt 
with nitrate preceded by a passive phase lasting only five 
minutes. In this study, the positivity rate was significantly 
higher with the classic 45-minute-long method (51% versus 
35%, p=0.04), suggesting that a longer passive phase would 
be necessary before administering the nitrate. However, this 
conclusion differs from other studies. Aerts et al52 assessed the 
HUTT with nitrate preceded by three passive tilt protocols: 
45 minutes, 30 minutes and without passive phase. The 
authors found sensitivities of 87%, 77% and 76%, respectively, 
and almost unchanged specificity of 83%, 83% and 82%, 
respectively. There was little difference in accuracy, although 
not statistically significant, of 78%, 80% and 71%, respectively. 
In addition, in this study, the sensitivity found was greater than 
in the study of Bartoletti et al38. This is a probable consequence 
of the selection of patients with typical clinical history of 
vasovagal syncope. 
More recently, Aerts and Dendale28 analyzed the accuracy of 
HUTT without passive phase. The tilt test was carried out with 
thirty-eight patients and thirty healthy subjects after administration 
of 400 ug of sublingual nitroglycerin, for a maximum period of 
30 minutes. The noted sensitivity was of 82%, the specificity was 
of 84% and the accuracy of 83%. The authors also reported that, 
when the results achieved at 15 minutes were analyzed, there 
was no significant decrease in sensitivity, which suggested that 
the test could be shorter. Furthermore, compared with previous 
studies, high sensitivity was found, which the authors attributed 
to the selection of patients that were strongly suspected of having 
vasovagal syncope.
The rate of false negatives in the HUTT during the 
investigation of vasovagal syncope is still significant - up to 30% 
when the nitrate is used14. Thus, new sensitizing drugs must 
be tested to reduce this rate. Examinations with false positives 
are less common, but studies show that, on average, 15% of 
patients with no history of syncope have a positive result. 
Undoubtedly, the elucidation of the mechanisms involved and 
the limits between the physiological response and pathological 
response will make it easier to interpret the test.
Other studies are also needed to define the usefulness of 
HUTT in the prognostic evaluation and treatment planning. 
On the other hand, the use for monitoring the VVS treatment 
depends primarily on the confirmation of the treatment 
effectiveness. Randomized and controlled studies have shown 
that some medications very used until some time ago and 
the use of implantable devices are not effective in reducing 
syncope events45,46,53.
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Conclusions
The head-up tilt test (HUTT) is a helpful tool in the 
investigation of unexplained syncope. The indiscriminate 
use, without well-demonstrated methodological criteria, may 
compromise the credibility and importance of HUTT. 
The test plays an important role in the differential diagnosis 
and it has been essential to help understand the hemodynamic 
changes related to dysautonomia. Perhaps, with the evolution 
of knowledge about the physiopathology and the treatment 
of these diseases, the results of HUTT can also be used in 
therapeutic guidance. 
The HUTT methodology has been improved over time. 
Thus, the proposed protocols should be evaluated considering 
possible false positives and false negatives, and future studies 
should be aimed at the development of methods that are more 
accurate without loss of specificity. 
In conclusion, HUTT is an important noninvasive test 
in the diagnostic evaluation of unexplained syncope, but it 
has limitations and sometimes it is not capable of defining 
the diagnosis. However, these imperfections do not justify 
abandoning the test. Instead, they justify trying to improve the 
technique. In clinical practice, HUTT is widely recognized, 
but the indication must be careful and the protocols shall 
be in accordance with what was proposed in international 
standards, so as to enable the correct interpretation of results. 
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